Last update 01 Nov 2024
Jiangxi Materia Medica Technology Co., Ltd.
Last update 01 Nov 2024
Overview
Tags
Respiratory Diseases
Infectious Diseases
Herbal medicine
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
No Data
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
荔桔爽含片治疗急性咽炎（外感风热证）有效性和安全性的随机、双盲、安慰剂平行对照、剂量探索、多中心研究
[Translation] A randomized, double-blind, placebo-controlled, dose-finding, multicenter study on the efficacy and safety of Lijushuang lozenges in the treatment of acute pharyngitis (exogenous wind-heat syndrome)
评价热感糖浆治疗普通感冒(风热证)有效性和安全性的多中心、随机、双盲、阳性药及安慰剂平行对照IIb期临床试验
[Translation] A multicenter, randomized, double-blind, active-drug and placebo-controlled phase IIb clinical trial to evaluate the efficacy and safety of Regan Tangsyuo in the treatment of common cold (wind-heat syndrome)
热感糖浆与安慰剂对照治疗感冒（风热证）随机、双盲、多中心临床试验
[Translation] A randomized, double-blind, multicenter clinical trial of heat syrup versus placebo in the treatment of cold (wind-heat syndrome)
100 Clinical Results associated with Jiangxi Materia Medica Technology Co., Ltd.
Login to view more data
Login to view more data
100 Deals associated with Jiangxi Materia Medica Technology Co., Ltd.
Login to view more data
100 Translational Medicine associated with Jiangxi Materia Medica Technology Co., Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 24 Nov 2024
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 2 Clinical
1
1
Other
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free